July 2013

Annual Results Investor Presentation

Table of contents

I. Business Overview & Highlights II. Financial Results III. Business Outlook IV. Appendices

Ian Bowles CEO

Business Overview & Highlights

2013 Financial highlights

Very strong H2 following slow H1 Revenue £37.1M; EBITDA £4.8M

Recurring revenue up to 47%

Cash generated from operations £8.7M

Underlying bookings trend stronger then revenue

UK Healthcare bookings exceed revenue by £5.5M

Deferred income up by £2.0M to £14.6M

1

11.1 12.5 14.1 16.2 18.9

2.3

9.0 10.4

10.4

4.6

7.2

7.0

10.0 7.8

15.7

22.0

30.1

36.6 37.1

2009A 2010A 2011A 2012A 2013A

UK Healthcare Other Healthcare Defence, Maritime & Other

Revenue by sector

Underpinned by growth of Healthcare revenue

£ in million

2

Business highlights 16 NHS Trusts selected HealthRoster 151 Trusts are now using Healthroster (50+% of NHS)

19 NHS Trusts renewed their HealthRoster contracts in 2013 33 Trusts since 2010 a renewal rate of 100%

The HealthRoster win rate this year was 88% 16 new wins included four competitive displacements. 13 NHS Trusts selecting a Medics Application for the first time

37 clients have HealthRoster v10 including 22 clients that have

migrated from v9

3

Healthcare significant achievements 2013

Launched HealthRoster v10 & Allocate Cloud Provides customers choice; improves customer retention and recurring

revenue

Development (existing products) Medics: Provides an integrated solution; customer need for revalidation

Clinical Activity Management: Developed in concert with HealthRoster and Medics

SafeCare: Developed in response to Francis report on Mid Staffordshire

Acquisition of RealTime Health Patient Flow: Will provide an holistic view of patent flow, bed management

Emergency Department: A critical need for NHS Trusts

4

The Allocate Cloud Additional delivery model launched at the user group in June

2012 Incremental revenue stream 24 customers contracted average annual contracted value: £29k bookings £2,318k; billings £710k; revenue £269k in FY 2013

Enabling customers to overcome infrastructure complexity, security and performance issues removes sales barriers

Faster deployment and upgrades margin enhancing

Flexible commercial models offering more predictable costs overcoming capex objections

Reinforce customer retention

5

Allocate International

Nordics

£7.4m of Revenue in 2013 (20% of total revenue)

Predominantly providing Healthrostering solutions (Time Care), with circa 10% of solutions into non-Healthcare markets

Continues to grow revenue and profits 22 new customers wins

Australia

£6.0m of Revenue in 2013 (16% of total revenue)

Focus on Healthcare… Acute (Healthsuite) Aged community care (Rosteron) Major multi year community

healthcare deal secured Rollout of major Australian project

behind original expectations

Defence Royal Australian navy Australian army Royal Australian air force

6

Defence

Enables the information management and analysis required to deliver military enterprise resource management

Revenue in 2013 of £5.0m, representing c.13% of total sales

Significant follow on order secured with the Royal Australian Air Force

Proof of Concept received from the UK Army. The complex and high-profile restructuring issues in project Future Reserves 2020 (FR20) will be managed under a services contract using Defence Suite 1. Resourcing: feeds from databases covering HR,

equipment, ammunition and fuel providing constant real-time assessment of availability

2. Forecasting: provides a view on likely future requirements based on clear rules and conditions

3. Costing: measurement, extraction and manipulation of costs to support financial cost modelling

Supports overall understanding

People

7

Maritime

Revenue in 2013 of £2.8m, representing 8% of total sales

Secured significant new Maritime Contracts in the Offshore Oil sector with McDermott and Technip based in the USA, and Subsea 7 an existing customer in the UK

Technip is important as MaritimeSuite has been viewed as such a success that they plan on implementing the solution worldwide within the Offshore Group

Both Allocate’s Maritime and Offshore suites focus on:

Scheduling

Capability

Operations

8

Chris Gale CFO

Financial Results

Financial highlights

2013 sales and EBITDA of £37.1m and £4.8m respectively

Revenue CAGR of 24% over last 4 years

Higher than usual operating expenses, due to acquisitions and R&D expenditure, impacting on margins (falling to 12%)

Broadly flat cost base going forward providing scope for margin enhancement

Improving revenue quality, with recurring/repeat revenues now standing at 47%

Evolution of business model and shift towards subscription rather than upfront licence understates the implied flat growth on prior year. Closing deferred income of £14.6m, up £2.0m on prior year

Strong operating cash of £8.7m driven by working capital management and evolution of business model

Net cash position of £9.1m versus £4.3m in 2012

9

Revenue breakdown 2013

2013 Revenue by type 2013 Revenue by geography 2013 Revenue by sector

26%

17%

31%

26%

Licence Perm/TermSubscriptions/SaasSupport & MaintenanceServices

55%

23%

16%

5% 1%

UKEuropeAustraliaUSARoW

79%

13%

8%

HealthcareDefenceMaritime/LG&E/Other

£ 37.1 million £ 37.1 million £ 37.1 million

10

UK Healthcare revenue 2013

Healthroster 64% of revenue Revenue model: Licensing Key solutions: Nurse Rostering, Locum/Bank management Integration of Patient Flow / ED and Safecare

Healthmedics 17% of revenue Revenue model: licensing / subscription Key solutions: Service planning, Consultant job planning, Junior doctor rotas, Appraisal and Revalidation, 360o multi source feedback

Healthassure 10% of revenue Revenue model: subscription Key solutions: Compliance, Realtime Assurance

Cloud 2% of revenue Key solutions: Allocate hosts and maintains software and associated data independent of provision of licence

Other 7% of revenue

SafeCare/Patient Acuity

11

Total revenue and EBITDA

Revenue and EBITDA

16.0

20.6

36.6

16.1

21.0

37.1

1.6

4.8 6.4

0.6

4.3 4.8

10%

23% 17%

4%

20% 13%

H1 2012A H2 2012A FY 2012A H1 2013A H2 2013A FY 2013A

Revenue EBITDA EBITDA Margin

£ in million

12

Revenue by type and recurring revenue

Improving revenue model

7.6 8.5 10.3 10.4 9.7

0.8 3.5 5.4 6.3

3.4 5.9

7.9 10.1 11.3

4.6

6.8

8.4

10.7 9.8

15.6

22.0

30.1

36.6 37.1

22%

30%

38%

42%

47%

2009A 2010A 2011A 2012A 2013A

Licence Perm/Term Subscriptions Support & Maintenance Services % Recurring Revenue

£ in million

13

Income statement trend

(£ in ‘000) H1

2012A

H1

2013A H1

Change H2

2012A H2

2013A H2

Change 2012A 2013A Change

Revenue 16,016 16,079 63 20,632 20,993 361 36,649 37,072 423

COGS 5,541 5,142 (399) 5,727 6,056 329 11,268 11,197 (71)

Gross Margin 10,475 10,937 462 14,905 14,937 32 25,380 25,874 494

Operating Expenses 9,091 10,579 1,488 10,278 10,888 610 19,369 21,467 2,098

R&D 3,333 3,686 353 3,597 3,956 359 6,931 7,643 712

Sales, Mktg, G&A 5,757 6,892 1,135 6,681 6,932 251 12,438 13,824 1,386

EBITA 1,384 358 (1,026) 4,627 4,050 (577) 6,011 4,407 (1,604)

EBITDA 1,581 569 (1,012) 4,825 4,269 (556) 6,397 4,838 (1,559) Gross Margin as % of Revenue 65.4% 68.0% 72.2% 71.2% 69.3% 69.8%

EBITDA as % of Revenue 9.9% 3.5% 23.4% 20.3% 17.5% 13.1%

EBITA as % of Revenue 8.6% 2.2% 22.4% 19.3% 16.4% 11.9%

14

Deferred income trend

0

1,000,000

2,000,000

3,000,000

4,000,000

5,000,000

6,000,000

7,000,000

H1 FY12 Q4 FY12 H1 FY13 Q4 FY13

Bal

ance

def

erre

d £

Support and maintenance

Subscriptions

CLOUD

£’000 H1 FY12 FY12 H1 FY13 FY13 Change FY12-FY13

% Change FY12-FY13

Support and maintenance 3,413 5,869 5,499 6,844 975 17% Subscriptions 2,841 4,217 3,565 5,093 876 21% CLOUD (and external) 69 87 410 459 372 428% Sub-total 6,323 10,173 9,474 12,396 2,223 22% Services 1,389 2,019 2,311 1,946 (73) -4% Licence (and other) 613 392 56 238 (154) -39% Balance sheet total 8,325 12,584 11,841 14,580 1,996 16%

15

DSO and receivables ageing

Allocate Software PLC (Consolidated) Aged Debtors – 31 May 2013

Q4 FY13 Q4 FY12

£’000 % £’000s % Current 6,751 72% 7,777 64%

0 to 30 days 1,606 17% 2,119 17%

31 to 60 days 343 4% 1,204 10%

61 to 90 days 472 5% 466 4%

91 days+ 253 3% 557 5%

Total 9,426 100% 12,123 100%

Days Sales Outstanding £’000 FY13 FY12

Q4 Q3 Q2 Q1 Q4 Trade receivables 9,426 5,306 7,907 4,940 12,123 Quarterly revenue 13,500 7,493 10,125 5,954 9,867 DSO at Qtr End 64 65 71 76 112

16

Business Outlook

Ian Bowles CEO

Positive Healthcare market dynamics

Global and growing market

UK A&E attendances up 50% on ten years ago

Routine operations jumped by 60% since the mid 1990s

Impact of rising life expectancies; 3 x more elderly people in 2050 than the beginning of century

People over 85 now accounting for a quarter of hospital beds, typically spending 11 days (vs. 3 for under 65s)

Pressure to increase efficiencies and cut costs throughout the Healthcare process

Quality of patient care and safe staffing levels a key area of focus

A&E in crisis - issues with bed management and target wait times

Importance of efficient patient flow – getting patients firstly out of A&E and then back into care in the community quickly

Innovation critical to addressing supply issues and providing Allocate with increased opportunity

Demand Supply

UK Healthcare IT market = approx. £1bn per year

Source: EHI and NHS Information Centre for Health and Social Care.

17

Market Environment

The Francis II report on the Mid Staffordshire Trust Recommends evidence-based tools for establishing the staffing

needs of each service

The Keogh report on patient care across NHS Trusts Allocate products address many of the recommendations

A&E departments are now stated to be in crisis RealTime ED & Patient Flow applications address many of the

issues

18

Comprehensive product portfolio to address Healthcare

SafeCare

19

Responding to customer needs

Application Benefits Summary

Patient Flow / ED • Provides clinically informed patient flow

• Reduces length of stay, releasing capacity for NHS, saving costs and increasing income

• RealTime product • 8 NHS Customers

CAM (Clinical Activity Management)

• Revolutionary way to plan, manage & integrate medics with other teams

• Fully integrated with HealthRoster, it improves patient care and encourages medical engagement

• Internally developed • Restricted release with 2

customers

SafeCare • Enables senior nursing staff to staff according to patient numbers an acuity

• Safer staffing for patients

• Internally developed • Launched January 2013 • High and predictable

renewal rate

20

2014 Revenue predictability

Revenue predictability FY14 Outlook (% total)

Deferred revenue 28%

Existing customers, Subscriptions and Support and Maintenance and Licence Renewals 56%

Existing customers, from Purchase Orders in hand 59%

Existing customers, existing products 73%

New or existing customers, existing products 83%

New or existing customers, new products 100%

21

2014 Outlook and key objectives

Drive success of the RealTime products

Maintain growth trajectory of Cloud and Medics

Secure 100% HealthRoster licence renewals

Maintain growth trajectory in Nordics

Upgrade 40% of the HealthRoster installed base to HealthRoster v10

Drive margin expansion through operating efficiencies and improved return on investments

22

Company position and strengths

Leading provider of Healthcare software to the UK market - Comprehensive and complementary product suite - Strong existing customer base around Healthroster

1

Positive market dynamics - Growing demand and Healthcare sector efficiency needs - Technology change driving demand for cloud based solutions

2

Continuous product innovation driving growth - Leveraging position as trusted advisor to upsell additional product (CAM, Realtime) - Improved delivery platforms (Allocate v.10; The Allocate Cloud)

4

Management team with experience and ability to scale the business - Significant software and Healthcare experience - Proven track record of driving growth, both organic and through acquisition

5

Attractive financial profile - Improving recurring revenue profile and margin expansion - R&D and acquisition investment in place to support future growth

6

Powerful franchise in workforce optimisation - Dominant market position with the NHS with track record of displacing competition - ‘Sticky’ model once embedded with a customer

3

23

Appendices

Allocate Vision

24

Allocate management team Significant software and Healthcare experience Terry Osborne Ian Bowles Chris Gale Allen Swan

Title Chairman Chief Executive Officer Chief Financial Officer Business Development Director

Experience Joined Allocate in 2005 VP roles at IBM (UK & US) between 1967 and 1985 Special Adviser to SSA LTD7

Joined Allocate in 2007 Previously COO of Clearswift Limited. Other senior positions held at Interwoven, Chordiant and Oracle

Joined Allocate in 2010 Various previous senior financial roles held at Apple, Cooper and Chyan Inc, Cadence, Interwoven and Clearswift

Prime Response and Oracle Previous senior roles at Chordiant, Joined Allocate in 2008, previously acting as an adviser

Martin Jeffries Jan Watson Chris Farnath Iain Bishop

Title

Director of International Marketing HR Director International Support Director Chief Technology Officer

Experience

Joined Allocate in 2010 Joined Allocate in 2007 Joined Allocate in 2010 Over 20 years in technology services

Joined Allocate on 2011 Over 25 years industry experience

Hugh Ashley Peter Croft Erik Stone

Title

Director of Customer Services Regional Director Sales Director of TimeCare

Experience Former founder of Dynamic Change Joined Allocate as of 1/6/2011as the Acquisition was completed Appointed to current role 1/9/12

Was appointed to the role of Regional Director Joined 4/8/2010 Formerly GM of Asia Pacific for Clearswift

Erik was appointed to the role of Regional Director Nordics on 24/10/11

25

UK Healthcare licencing scheme summary

Allocate Software plcUK Healthcare Licencing Scheme Summary

Licence/Subs Revenue streams Licence/Subs Services Support & MaintenanceLicence type Delivery model Contract Period Lic Subs Serv S&M Revenue Recognition Revenue Recognition Revenue Recognition

Healthroster (new customers) Permanent/Term Customer site/Cloud 4-5 years X X X X Licence Upfront/Cloud rateable As delivered RateableHealthroster (renewing customers) Permanent/Term Customer site/cloud 4-5 years X X X X Licence Upfront/Cloud rateable As delivered Rateable

Real Time Patient Flow Permanent/Term Customer site 4-5 years X X X Upfront As delivered RateableReal Time Emergency Department Permanent/Term Customer site 4-5 years X X X Upfront As delivered Rateable

Clinical Activity Management (CAM) Permanent/Term Customer site 4-5 years X X X Upfront As delivered RateableBankstaff Permanent Customer site Permanent X X X Upfront As delivered RateableE-expenses Term Customer site up to 5 years Upfront As delivered RateableSafeCare Permanent/Term Customer site 4-5 years X X X Upfront As delivered Rateable

Cloud Subscription Hosted 4-5 years X X Rateable As delivered RateableMedics Subscription Hosted up to 5 years X X Rateable As delivered RateableHealth Assure Subscription Hosted up to 5 years X X Rateable As delivered Rateable

26

(£ in ‘000) 2012A 2013A Change % Change Non-current assets 18,214 15,573 (2,641) (14.5%) PP&E 908 868 (40) (4.4%) Goodwill 6,939 7,280 341 4.9% Intangible assets 9,661 5,949 (3,712) (38.4%)

Other financial assets 60 - Deferred tax asset 561 861 300 53.5% Trade and other receivable 85 615 Current assets 23,211 26,114 2,903 12.5% Corporation tax receivable 120 93 Trade and other receivable 14,753 12,887 (1,866) (12.6%) Cash and cash equivalent 8,338 13,134 4,796 57.5% Total assets 41,425 41,687 262 0.6% Equity 15,760 14,199 (1,561) (9.9%) Non-current liabilities 7,939 4,266 (3,673) (46.3%) Borrowings 4,000 0 (4,000) (100.0%) Deferred tax liability 2,129 1,449 (680) (31.9%) Trade and other payables 1,810 2,817 1,007 55.6% Current liabilities 17,726 23,222 5,496 31.0% Trade and other payables 17,085 18,832 1,747 10.2% Borrowings 0 4,000 4,000 Corporation tax 641 390 (251) (39.2%) Total liabilities 25,665 27,488 1,823 7.1% Total Equity and Liabilities 41,425 41,687 262 0.6%

Balance sheet trend

27

Cash flow statement £’000 FY12 Full year FY13 Full year Change % Change EBITA 6,003 4,407 (1,596) (26.6%) Depreciation 395 431 36 9.1% Net result on disposal of fixed assets 12 8 (4) (33.3%) Working Capital

Change in trade and other receivables (2,628) 1,619 4,247 (161.6%) Change in trade and other payables 1,604 2,278 674 42.0%

Operating cash flow (before acquisition costs) 5,385 8,743 3,358 62.4% Acquisition costs (1,544) (703) 841 (54.5%)

Operating cash flow (after acquisition costs) 3,841 8,040 4,199 109.3% Tax (301) (721) (420) 139.5% Proceeds from disposal of intangible asset 50 92 42 84.0% Capital expenditure (753) (531) 222 (29.5%)

Pre financing cashflow 2,837 6,880 4,043 142.5% Financing

Interest receivable 108 49 (59) (54.6%) Interest payable (123) (115) 8 (6.5%) Revolving facility 2,000 -

1,985 (66) (2,051) (103.3%) Investing Activities

Acquisition of RealTime - (1,162) Acquisition of RosterOn (2,210) - Acquisition of Zircadian (6,454) - Cash acquired with RealTime - 85 Cash acquired with RosterOn 586 - Cash acquired with Zircadian 1,256 LTRP Share Purchase - (600) FY12 Final Dividend (682) (682) Share issues 194 59 (135) (69.6%)

(6,628) (2,300) 4,328 (65.3%) Foreign exchange (255) 282 537 (210.6%) Cash generated/(utilised) (1,805) 4,514 6,320 (349.9%) Opening Cash 10,398 8,338 (2,060) (19.8%) Closing Cash 8,338 13,134 4,797 57.5%

28

Key statistics

Shares in issue, May 31: 64,205,528 Share price close, July 19: 83.50p

Major shareholders as of June 30:

Name of holder Number % of issued share capital

Herald Investment Management 11,736,477 18.3%

Artemis Fund Managers 8,650,000 13.5%

BlackRock Investment Management (UK) 7,196,763 11.2%

SVG Capital 5,841,535 9.1%

Hargreave Hale 4,749,951 7.4%

Kabouter Management LLC 3,697,999 5.8%

Jupiter Asset Management 3,304,104 5.2%

Henderson Global Investors 2,827,370 4.4%

Allianz Global Investors KAG 2,000,000 3.1%

29